Q2 STOCKS TO BUY

Biotech Stock Rises on Lofty Piper Sandler Bull Note

ILMN has gained over 39% in three months

Digital Content Manager
Dec 22, 2020 at 11:08 AM
facebook X logo linkedin


The shares of Illumina Inc. (NASDAQ:ILMN) are up 3.2% at $374.30 at last check, after the biotechnology concern received an upgrade from Piper Sandler to "overweight" from "neutral," as well as a price-target hike to $415 from $340. The analyst in coverage expressed confidence over cancer testing firm Grail's portfolio, which was purchased by Illumina in September. What's more, the firm said competition concerns with customers in the oncology space are overblown, and that COVID-19 vaccine approvals will reduce potential headwinds to its core business.

Illumina stock has had a volatile year so far. The shares more than doubled off their March 18, three-year lows of $196.78 to hit an Aug. 5 all-time-high of $404.20. A number of bear gaps ultimately knocked the security off those levels, however. Yet, the stock has been chopping higher on the charts of late, with support from the 20-day moving average. And in the last three months alone, ILMN has gained over 39%. 

Analysts were pessimistic toward the security coming into today, with 11 of the 16 in question carrying a tepid "hold" or worse rating. Echoing this is the stock's 12-month consensus target price of $315.75, which is a whopping 15.9% discount to its current perch. Should some of these bears follow Piper Sandler's lead, it could put additional wind at ILMN's back.  

That pessimism is reflected in the options pits, where puts are popular. This is per the security's 10-day put/call volume ratio of 2.81 at the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), which sits higher than 97% of readings from the past year. In simpler terms, puts are being picked up at a quicker-than-usual clip.

Today's bull note may be shifting the tide, however. So far, over 1,000 calls have already crossed the tape, which is twice the average intraday amount. Most popular is the 12/31 375-strike call, followed by the 12/24 370-strike call, with new positions being opened at both.

 
 

“Buy This Stock Now!” - Expert Who Called 11x On TSLA

He called a rare 11x on Tesla…

But now, thanks to Elon & Trump’s new alliance…

He says there’s a new opportunity that could be 1,000x BIGGER than Tesla – and it could completely revolutionize a $23 Trillion market.

It’s trading for less than $5 per share right now…

But it won’t be under the radar for long.

Discover The 1,000x Bigger Elon Opportunity Here

GRAND SLAM COUNTDOWN

 
 

Featured Articles from Trusted Partners:

👀Learn How Dividends Create Passive Income for Life
Receive $200 Off Motley Fool Epic. The Motley Fool Epic $299 discounted offer is based on $499/year list price. Introductory promotion for new members only. Take control of your money and your portfolio with Motley Fool Epic.

💵New Income System Could Pay You $4,243 Monthly
You could collect an average of $4,243 per month starting as early as next week with a new payout system for income investors. New registrations are being accepted for investors who want to be in a position to start with their first payout next week.

🚀Easy 92% Crypto Dividends (No Coins Required)
COIN stock doesn't pay a dividend... But there's actually a new way to collect a massive dividend that's indirectly based on the stock and offers a terrific monthly income (currently yielding nearly 92% on a forward basis).

🤝Free Advisor Match with Wiseradvisor.com
Don't leave your retirement to chance! Get matched with a trusted financial expert for FREE and make the most of your tax refund. Get started now.

⚠️Dennis Quaid's #1 Warning for Americans
Here's the thing: life doesn't come with guarantees. The economy shifts, markets stumble, and years of hard work could slip through your fingers like sand. But it doesn't have to be that way for you. So request a free copy of this Gold & Silver Guide that will arrive right to your doorstep when you act now.

 

 
 

Follow us on X, Follow us on Twitter